# AVT03 With Prolia in Healthy Male Subjects

> **NCT05126784** · PHASE1 · COMPLETED · sponsor: **Alvotech Swiss AG** · enrollment: 209 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **BIOLOGICAL:** AVT03
- **BIOLOGICAL:** Prolia

## Key facts

- **NCT ID:** NCT05126784
- **Lead sponsor:** Alvotech Swiss AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-29
- **Primary completion:** 2023-10-16
- **Final completion:** 2023-10-16
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126784, "AVT03 With Prolia in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05126784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*